Patents by Inventor Elin SÄWÉN

Elin SÄWÉN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10898613
    Abstract: A method of preparing a sterilized injectable hydrogel composition, including the steps: a) covalently crosslinking a glycosaminoglycan using a bi- or polyfunctional crosslinking agent to form a covalently crosslinked glycosaminoglycan, b) swelling the covalently crosslinked glycosaminoglycan in a solution including a divalent cation to form a hydrogel composition, and c) sterilizing the hydrogel composition by autoclaving to form a sterilized injectable hydrogel composition, and to sterilized injectable hydrogel compositions obtainable by such method.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: January 26, 2021
    Assignee: NESTLÉ SKIN HEALTH SA
    Inventors: Laura Jing Jing, Craig Steven Harris, Anders Karlsson, Elin Säwén
  • Patent number: 10533061
    Abstract: A hyaluronic acid product including a cross-linked hyaluronic acid and one or more cyclodextrin molecules. The hyaluronic acid is cross-linked by ether bonds, and the one or more cyclodextrin molecules are grafted onto the cross-linked hyaluronic acid by amide bonds, preferably using a triazine-based coupling reagent. A process of preparing a hyaluronic acid product including a cross-linked hyaluronic acid and one or more cyclodextrin molecules.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: January 14, 2020
    Assignee: Galderma S.A.
    Inventors: Jean-Guy Boiteau, Elin Säwén
  • Publication number: 20190351105
    Abstract: A method of preparing a sterilized injectable hydrogel composition, including the steps: a) covalently crosslinking a glycosaminoglycan using a bi- or polyfunctional crosslinking agent to form a covalently crosslinked glycosaminoglycan, b) swelling the covalently crosslinked glycosaminoglycan in a solution including a divalent cation to form a hydrogel composition, and c) sterilizing the hydrogel composition by autoclaving to form a sterilized injectable hydrogel composition, and to sterilized injectable hydrogel compositions obtainable by such method.
    Type: Application
    Filed: September 20, 2017
    Publication date: November 21, 2019
    Applicant: Nestlé Skin Health SA
    Inventors: Laura Jing JING, Craig Steven HARRIS, Anders KARLSSON, Elin SÄWÉN
  • Publication number: 20180265600
    Abstract: A hyaluronic acid product including a cross-linked hyaluronic acid and one or more cyclodextrin molecules. The hyaluronic acid is cross-linked by ether bonds, and the one or more cyclodextrin molecules are grafted onto the cross-linked hyaluronic acid by amide bonds, preferably using a triazine-based coupling reagent. A process of preparing a hyaluronic acid product including a cross-linked hyaluronic acid and one or more cyclodextrin molecules.
    Type: Application
    Filed: December 17, 2015
    Publication date: September 20, 2018
    Inventors: Jean-Guy BOITEAU, Elin Saewen
  • Publication number: 20180155456
    Abstract: A process of preparing a cross-linked polysaccharide product including hyaluronic acid and dextran, the process including the steps of: (a) providing a hyaluronic acid and a dextran; (b) binding the dextran to the hyaluronic acid by ether bonds using a bi- or polyfunctional cross-linking agent, wherein the hyaluronic acid provided in step (a) is a cross-linked hyaluronic acid gel, and the dextran provided in step (a) is a non-cross-linked dextran; and wherein step (b) includes cross-linking the dextran to the hyaluronic acid by ether bonds using a bi- or polyfunctional cross-linking agent.
    Type: Application
    Filed: May 29, 2015
    Publication date: June 7, 2018
    Applicant: GALDERMA S.A.
    Inventors: Anders KARLSSON, Hotan MOJARRADI, Elin SÄWÉN